SET and neoplasm: Another study indicates that CBX8 and SET/TAF-Iβ co-bind to the tumor suppressor SUSD2 promoter to establish H2AK119ub and prevent the acetylation of histone H3, resulting in transcriptional suppression of SUSD2 (53).